Dr. Leanne Chiemi Leung is a pharmacist who is specialized in Pharmacotherapy in Roseville, California. Patients can reach her at 1001 Riverside Ave, Roseville or contact her on 916-746-4609. Active license number of Dr. Leanne Chiemi Leung is 51703 for Pharmacotherapy in California. Dr. Leanne Chiemi Leung is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Leanne Chiemi Leung speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Leanne Chiemi Leung are as mentioned below.
NPI Number:
1467527804
NPI Enumeration Date:
21 Nov, 2006
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Leanne Chiemi Leung are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
51703
California
Primary
Pharmacotherapy
PH-2395
Hawaii
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1001 Riverside Ave, Roseville, California
Zip:
95678-5134
Phone Number:
919-543-4287
Fax Number:
--
Patients can reach Dr. Leanne Chiemi Leung at 1001 Riverside Ave, Roseville, California or can call on phone at 916-746-4609.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.